Featured Research

from universities, journals, and other organizations

Off-label Use Often Not Evidence-Based: Physicians Lack Knowledge Of Off-label Drug Use And FDA Approval Status, Study Finds

Date:
August 23, 2009
Source:
University of Chicago Medical Center
Summary:
In a recent national survey, a substantial minority of physicians erroneously believed that certain off-label uses of prescription drugs were FDA approved. This mistaken belief encourages them to prescribe these drugs, despite the lack of scientific evidence supporting such use. Overall, physicians were able to correctly identify the FDA-approval status of just over half of the 22 drug-indication pairs (i.e., a particular drug prescribed for a particular condition) included in the survey.

In a recent national survey, a substantial minority of physicians erroneously believed that certain off-label uses of prescription drugs were approved by the Food and Drug Administration. This mistaken belief could encourage them to prescribe these drugs, despite the lack of scientific evidence supporting such use.

"Off-label prescribing is common, but researchers have not always known why. Our research shows that some off-label prescribing might be driven by mistaken beliefs about FDA approval and the level of evidence supporting off-label drug use," said G. Caleb Alexander, MD, MS, Assistant Professor of Medicine at the University of Chicago Medical Center and corresponding author of the research, which will be published in the journal Pharmacoepidemiology and Drug Safety.

"The results indicate an urgent need for more effective methods of informing physicians about the level of evidence supporting off-label drug use—especially for common off-label uses that are ineffective or carry unacceptable risks of harm."

Overall, physicians were able to correctly identify the FDA-approval status of just over half (mean 55%) of the 22 drug-indication pairs (i.e., a particular drug prescribed for a particular condition) that were included in the survey.

In many cases, the proportion of physicians who erroneously believed a particular drug was FDA approved for a specific indication was higher among physicians who had prescribed the drug for that indication.

For example, 26% of all physician respondents erroneously believed that lorazepam was FDA approved for chronic anxiety. That figure rose to 33% for physicians who had prescribed lorazepam for chronic anxiety.

And 13% of all physician respondents erroneously believed that quetiapine (SeroquelŪ) was FDA approved for dementia with agitation. That figure rose to 19% for physicians who had prescribed quetiapine for dementia with agitation. At the time of the study there was even an FDA-advisory specifically urging caution regarding the off-label use of quetiapine in patients with dementia.

The survey of 1,199 physicians (599 primary care physicians and 600 psychiatrists) was conducted in 2007-2008 and included 22 drug-indication pairs. The indications varied in their FDA approval status from on-label use to off-label use supported by medical evidence to off-label use deemed to be ineffective. (The level of evidence supporting or not supporting each specific use was based on Drugdex, an independent drug compendium.)

The FDA makes it clear that they regulate the marketing of prescription drugs, not prescribing. The agency approves drugs for marketing with an official "label" that stipulates an indication, dose, intended population, duration of use, and other specifications. However, physicians and other licensed prescribers are free to prescribe any approved drug for any indication, whether or not the indication is included on the drug's FDA-approved label.

"Some physicians and health care experts maintain that physicians should know the evidence, not the FDA labeling. However, knowledge about FDA labeling can be important because FDA approval of a drug for a specific indication indicates a clear threshold of evidence supporting that use," said Donna Chen, MD, Assistant Professor of Biomedical Ethics, Public Health Sciences, and Psychiatry at the University of Virginia. Dr. Chen is the lead author of the research, entitled "U.S. physician knowledge of the FDA-approved indications and evidence base of commonly prescribed drugs: results of a national survey".

A study published in the Archives of Internal Medicine by other investigators in 2006 indicated that approximately 21% of drug uses in the United States occur for off-label purposes, with 73% of those cases lacking scientific evidence of the drug's effectiveness. The highest rates of off-label use were for anticonvulsants (74%), antipsychotics (60%) and antibiotics (41%).

"We hope our research will increase awareness of off-label prescribing and highlight the pressing need for more evidence-based use of prescription drugs," Alexander said. "Although some off-label uses are well-supported, many are not. New ways are needed to help physicians tap the scientific evidence supporting various prescription drug uses."

Some disadvantages of off-label use:

  • May diminish public expectation that drugs will be evaluated for safety and efficacy before use
  • Blunts industry incentives to perform studies required for FDA label changes
  • Drugs used off label may have unrecognized safety and efficacy problems
  • Promotes use of drugs in populations (e.g., children, the elderly) for which they have not been tested

Some advantages of off-label use:

  • Allows for clinical innovation, especially for patients who do not respond to standard treatments
  • May be only available option for uncommon conditions or for patient populations that have not been studied
  • Allows physicians to anticipate growing evidence of efficacy prior to formal evaluation
  • Increases return on investment for pharmaceutical firms

Source: G. Caleb Alexander, MD, MS, Assistant Professor of Medicine at the University of Chicago Medical Center


Story Source:

The above story is based on materials provided by University of Chicago Medical Center. Note: Materials may be edited for content and length.


Journal Reference:

  1. Donna T. Chen, Matthew K. Wynia, Rachael M. Moloney, G. Caleb Alexander. U.S. physician knowledge of the FDA-approved indications and evidence base for commonly prescribed drugs: results of a national survey. Pharmacoepidemiology and Drug Safety, 2009; n/a DOI: 10.1002/pds.1825

Cite This Page:

University of Chicago Medical Center. "Off-label Use Often Not Evidence-Based: Physicians Lack Knowledge Of Off-label Drug Use And FDA Approval Status, Study Finds." ScienceDaily. ScienceDaily, 23 August 2009. <www.sciencedaily.com/releases/2009/08/090821135011.htm>.
University of Chicago Medical Center. (2009, August 23). Off-label Use Often Not Evidence-Based: Physicians Lack Knowledge Of Off-label Drug Use And FDA Approval Status, Study Finds. ScienceDaily. Retrieved July 31, 2014 from www.sciencedaily.com/releases/2009/08/090821135011.htm
University of Chicago Medical Center. "Off-label Use Often Not Evidence-Based: Physicians Lack Knowledge Of Off-label Drug Use And FDA Approval Status, Study Finds." ScienceDaily. www.sciencedaily.com/releases/2009/08/090821135011.htm (accessed July 31, 2014).

Share This




More Health & Medicine News

Thursday, July 31, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Health Insurers' Profits Slide

Health Insurers' Profits Slide

Reuters - Business Video Online (July 30, 2014) — Obamacare-related costs were said to be behind the profit plunge at Wellpoint and Humana, but Wellpoint sees the new exchanges boosting its earnings for the full year. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com
Concern Grows Over Worsening Ebola Crisis

Concern Grows Over Worsening Ebola Crisis

AFP (July 30, 2014) — Pan-African airline ASKY has suspended all flights to and from the capitals of Liberia and Sierra Leone amid the worsening Ebola health crisis, which has so far caused 672 deaths in Guinea, Liberia and Sierra Leone. Duration: 00:43 Video provided by AFP
Powered by NewsLook.com
At Least 20 Chikungunya Cases in New Jersey

At Least 20 Chikungunya Cases in New Jersey

AP (July 30, 2014) — At least 20 New Jersey residents have tested positive for chikungunya, a mosquito-borne virus that has spread through the Caribbean. (July 30) Video provided by AP
Powered by NewsLook.com
Xtreme Eating: Your Daily Caloric Intake All On One Plate

Xtreme Eating: Your Daily Caloric Intake All On One Plate

Newsy (July 30, 2014) — The Center for Science in the Public Interest released its 2014 list of single meals with whopping calorie counts. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

    Environment News

    Technology News



      Save/Print:
      Share:  

      Free Subscriptions


      Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

      Get Social & Mobile


      Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

      Have Feedback?


      Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
      Mobile iPhone Android Web
      Follow Facebook Twitter Google+
      Subscribe RSS Feeds Email Newsletters
      Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins